Joseph Michael Fitzgerald - Feb 16, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Group Pres, Cardiology
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 16, 2023
Transactions value $
-$264,751
Form type
4
Date filed
2/21/2023, 03:19 PM
Previous filing
Feb 21, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +3.96K +1.87% $0.00 216K Feb 16, 2023 Direct F1
transaction BSX Common Stock Tax liability -$83.9K -1.81K -0.84% $46.48 214K Feb 16, 2023 Direct
transaction BSX Common Stock Options Exercise $0 +4.17K +1.94% $0.00 218K Feb 17, 2023 Direct F1
transaction BSX Common Stock Tax liability -$95.7K -2.06K -0.94% $46.54 216K Feb 17, 2023 Direct
transaction BSX Common Stock Options Exercise $0 +3.71K +1.71% $0.00 220K Feb 18, 2023 Direct F2
transaction BSX Common Stock Tax liability -$85.1K -1.83K -0.83% $46.54 218K Feb 18, 2023 Direct
holding BSX Common Stock 68.1K Feb 16, 2023 By 401(k) F3
holding BSX Common Stock 4.34K Feb 16, 2023 By Child F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -3.96K -25% $0.00 11.9K Feb 16, 2023 Common Stock 3.96K Direct F1, F5
transaction BSX Restricted Stock Units Options Exercise $0 -4.17K -33.33% $0.00 8.33K Feb 17, 2023 Common Stock 4.17K Direct F1, F6
transaction BSX Deferred Stock Units Options Exercise $0 -3.71K -50% $0.00 3.71K Feb 18, 2023 Common Stock 3.71K Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F4 The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F6 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.